Intervention not reported
Cough‐free days Percentage of days free of cough · 18 to 80 years of age with bronchiectasis
The intervention may leads to higher cough‐free days Percentage of days free of cough (low certainty).
1 finding from 1 review
Protection from experiencing an asthma exacerbation of any cause over the influenza season ‐ children (over 6 years of age) given inactivated influenza vaccine · people with asthma
1 finding from 1 review
Protection from experiencing an influenza‐related asthma exacerbation over the influenza season ‐ children (over 6 years of age) given inactivated influenza vaccine · people with asthma
1 finding from 1 review
Asthma exacerbation (adverse effects) caused by inactivated influenza vaccine, measured in the first 2 weeks following vaccination ‐ children (over 3 years of age) given inactivated influenza vaccine · people with asthma
1 finding from 1 review
Intervention not reported
Quality of life1 Paediatric Asthma Quality of Life Questionnaire (PAQLQ). Scale from: 1 (worse) to 7 (better). · children and adolescents aged 18 years and under studies with asthma
1 finding from 1 review
Intervention not reported
Asthma symptoms Different scales in different studies (lower scores mean fewer symptoms) · children and adolescents aged 18 years and under studies with asthma
1 finding from 1 review
Intervention not reported
Exacerbations requiring hospital admission · children and adolescents aged 18 years and under studies with asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Exacerbations requiring a course of oral corticosteroids · children and adolescents aged 18 years and under studies with asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Urgent asthma physician visits1 Number of times the child visited a physician's office/clinic for an asthma flare up · children and adolescents aged 18 years and under studies with asthma
1 finding from 1 review
Intervention not reported
Resting lung function Forced expiratory volume (FEV1) in 1 second (litres) · children and adolescents aged 18 years and under studies with asthma
1 finding from 1 review
Intervention not reported
Fitness6 Maximal oxygen consumption (VO2 max) · children and adolescents aged 18 years and under studies with asthma
1 finding from 1 review
Cost‐effectiveness · management of bronchiectasis
1 finding from 1 review
no estimate extracted
Studies not reported
Low
FEV1 · participants with stable stage 2 and 3 COPD (mainly FEV1 49 ± 12% predicted), ex‐smokers (majority), smokers and non‐smokers
1 finding from 1 review
Linear growth velocity (cm/year) · children up to 18 years of age with persistent asthma
Effects of different inhaled corticosteroids on growth in children… may leads to higher linear growth velocity (cm/year) compared with beclomethasone (low certainty).
1 finding from 1 review
Linear growth velocity (cm/year) · children up to 18 years of age with persistent asthma
It is very uncertain whether effects of different inhaled corticosteroids on growth in children… changes linear growth velocity (cm/year) compared with budesonide (very low certainty).
1 finding from 1 review
Change in height · children up to 18 years of age with persistent asthma
Effects of different inhaled corticosteroids on growth in children… probably leads to higher change in height (cm) over a period of time compared with budesonide (moderate certainty).
1 finding from 1 review
Linear growth velocity (cm/year) · children up to 18 years of age with persistent asthma
Effects of different delivery devices on growth in children with… showed no clear difference in linear growth velocity (cm/year) compared with chlorofluorocarbon‐metered dose inhaler beclomethasone (low certainty).
1 finding from 1 review
Change in height · children up to 18 years of age with persistent asthma
Effects of different delivery devices on growth in children with… may leads to higher change in height (cm) over a period of time compared with turbuhaler‐budesonide (low certainty).
1 finding from 1 review
Hospital admissions · children with asthma
Caseworker‐assigned discharge plans probably leads to lower hospitalisation compared with non‐caseworker‐assigned plans (moderate certainty).
1 finding from 1 review
ED visits · children with asthma
Caseworker‐assigned discharge plans showed no clear difference in emergency department visit compared with non‐caseworker‐assigned plans (low certainty).
1 finding from 1 review